Cargando…

Origins of systemic lupus erythematosus: genes, environment, and host immune response

Detalles Bibliográficos
Autores principales:	Harley, JB, Kelly, JA, James, JA
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833817/ http://dx.doi.org/10.1186/ar827

Ejemplares similares

Autoantibodies and cognitive impairment in systemic lupus erythematosus
por: Kowal, C, et al.
Publicado: (2004)

Epidemiology of foot complaints in systemic lupus erythematosus
por: Otter, S, et al.
Publicado: (2015)

Analysis of B-cell subpopulations in systemic lupus erythematosus
por: Dorner, T, et al.
Publicado: (2003)

O08 A case of juvenile systemic lupus erythematosus with pyrexia of unknown origin
por: Warrier, Kishore, et al.
Publicado: (2021)

Insights into systemic lupus erythematosus pathogenesis through blood global gene expression analysis
por: Pascual, V, et al.
Publicado: (2004)

Subclinical cardiovascular abnormalities in patients with juvenile systemic lupus erythematosus
por: Canpolat, Nur, et al.
Publicado: (2011)

Analysis of growth in female patients with pediatric-onset systemic lupus erythematosus
por: Mak, NC, et al.
Publicado: (2011)

Defective removal of ribonucleotides from DNA promotes systemic lupus erythematosus
por: Günther, C, et al.
Publicado: (2015)

Prevalence and demographics of systemic lupus erythematosus and lupus nephritis among US children with Medicaid coverage, 2002-2004
por: Hiraki, Linda T, et al.
Publicado: (2012)

Failure of receptor revision in the autoreactive B cells in patients with systemic lupus erythematosus
por: Yoshikawa, H, et al.
Publicado: (2003)

Long-term education and employment outcomes in pediatric-onset systemic lupus erythematosus
por: Lawson, Erica F, et al.
Publicado: (2012)

Foot problems in patients with systemic lupus erythematosus; under-reported and under-treated?
por: Otter, S, et al.
Publicado: (2015)

OA14 The role of anifrolumab in treating life threatening systemic lupus erythematosus with severe mucocutaneous involvement
por: Baldwin, Christopher, et al.
Publicado: (2023)

Follow up study of B-lymphocyte depletion in the treatment of patients with systemic lupus erythematosus
por: Leandro, MJ, et al.
Publicado: (2005)

14.2 Causes of early death in juvenile onset systemic lupus erythematosus (JSLE)
por: Bader-Meunier, B, et al.
Publicado: (2008)

Clinical phenotype of neonatal lupus erythematosus relates to autoantibody level and gender
por: Venkatesan, S, et al.
Publicado: (2011)

Defining clinical remission and clinically inactive disease in juvenile systemic lupus erythematosus (jSLE)
por: Mina, Rina, et al.
Publicado: (2011)

Myocardial tissue characterisation with late gadolinium enhancement in rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis
por: Ntusi, Ntobeko A, et al.
Publicado: (2013)

9.4 Autoantibodies in pediatric systemic lupus erythematosus: ethnic grouping, autoantibody clustering and clinical correlations
por: Jurencak, R, et al.
Publicado: (2008)

PD-L1 expression on monocytes marks active systemic lupus erythematosus in patients without nephritis
por: Stevens, Anne M, et al.
Publicado: (2012)

Native T1 mapping by cardiovascular resonance imaging detects subclinical cardiomyopathy in patients with systemic lupus erythematosus
por: Puntmann, Valentina O, et al.
Publicado: (2013)

Regulating innate immune response cytokines in synovitis
por: McInnes, IB, et al.
Publicado: (2004)

O07 Managing relapsing and refractory lupus nephritis in juvenile systemic lupus erythematosus: a case report
por: Javed, Farhan, et al.
Publicado: (2021)

Evaluation of autoantibody profiles in a cohort of new-onset pediatric systemic lupus erythematosus patients using autoantigen microarray technology
por: Balboni, Imelda M, et al.
Publicado: (2012)

A Phase I trial of B-cell depletion with anti-CD20 monoclonal antibody (rituximab) in the treatment of systemic lupus erythematosus
por: Eisenberg, R, et al.
Publicado: (2003)

Abnormal myocardial perfusion correlates with impaired systolic strain and diastolic strain rate in systemic lupus erythematosus: a cardiovascular magnetic resonance study
por: Ntusi, Ntobeko A, et al.
Publicado: (2015)

19. A case of giant cell arteritis (GCA) co-existent with systemic lupus erythematosus (SLE)/rheumatoid arthritis (RA) overlap syndrome
por: Steward, Matthew, et al.
Publicado: (2019)

3.5 Comparison of functional ability in juvenile idiopathic arthritis, juvenile dermatomyositis, juvenile systemic lupus erythematosus and healthy controls. An analysis of the PRINTO database
por: Filocamo, G, et al.
Publicado: (2008)

Impaired energetics and normal myocardial lipids in rheumatoid arthritis and systemic lupus erythematosus: a phosphorous and proton magnetic resonance spectroscopy and cardiovascular magnetic resonance study
por: Ntusi, Ntobeko A, et al.
Publicado: (2015)

PReS-FINAL-2175: Pharmacokinetics of mycophenolate mofetil in children with lupus and clinical findings in favour of therapeutic drug monitoring
por: Woillard, JB, et al.
Publicado: (2013)

Gene-environment in the induction of cancer
por: Autrup, Herman
Publicado: (2010)

Novel heterozygous mutations of the SF1 gene and their functional characterization in patients with 46,XY disorders of sex development (DSD) without adrenal insufficiency
por: Choi, Jin-Ho, et al.
Publicado: (2015)

P121 Effect of corticosteroids on the host innate immune response and in vitro growth characters during dermatophyte infection.
por: Sharma, Arunima, et al.
Publicado: (2022)

Establishing a normative database for the sagittal configuration of the spine using an objective three dimensional measurement tool (the MIDAS System)
por: Bettany-Saltikov, JA, et al.
Publicado: (2009)

A genetic analysis of lupus
por: Theofilopoulos, AN
Publicado: (2004)

The bovine leukemia virus microRNAs permit escape from innate immune response and contribute to viral replication in the natural host
por: Gillet, Nicolas A, et al.
Publicado: (2015)

Envisioning new targets and new approaches for molecular-based cancer therapeutics
por: Tainer, JA
Publicado: (2005)

Harnessing host innate immunity may combat acquired resistance to BRAFi
por: Tan, Thomas, et al.
Publicado: (2014)

Overexpression of CREMαlpha accelerates onset and severity of auto-immune mediated disease in a murine model of lupus
por: Ohl, Kim, et al.
Publicado: (2011)

OA06-05. Adaptation of HIV-1 to the human immune system at the population level is driven by protective HLA-B alleles
por: Schellens, IM, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3i4o7ddig2bat78pqr35ekkgul